1. Ahmed, S. U., Gorukanti, S. R., and Chowdhury, T. A., Ondansetron orally disintegrating tablets. U.S. Patent 7,390,503 (2008).
2. Balasubramaniam, J. and Bee, T., Influence of superdisintegrants on the rate of drug dissolution from oral solid dosage forms. Pharm. Tech. Suppl., S4–S14 (2009).
3. Barakat, N. S., Elbagory, I. M., and Almurshedi, A. S., Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Drug Deliv., 16, 57–65 (2009).
4. BASF, Superdisintegrants and dissolution enhancers. http://www.pharma-ingredients.basf.com/Home.aspx (2010).
5. Battu, S. K., Repka, M. A., Majumdar, S., and Madhusudan, R. Y., Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev. Ind. Pharm., 33, 1225–1232 (2007).